Nothing Special   »   [go: up one dir, main page]

Cervena et al., 2020 - Google Patents

Methylation-based therapies for colorectal cancer

Cervena et al., 2020

View HTML
Document ID
9779444061998680117
Author
Cervena K
Siskova A
Buchler T
Vodicka P
Vymetalkova V
Publication year
Publication venue
Cells

External Links

Snippet

Colorectal carcinogenesis (CRC) is caused by the gradual long-term accumulation of both genetic and epigenetic changes. Recently, epigenetic alterations have been included in the classification of the CRC molecular subtype, and this points out their prognostic impact. As …
Continue reading at www.mdpi.com (HTML) (other versions)

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Hybridisation probes
    • C12Q1/6883—Hybridisation probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Hybridisation probes for diseases caused by alterations of genetic material for cancer
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6813—Hybridisation assays
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay
    • G01N33/574—Immunoassay; Biospecific binding assay for cancer
    • G01N33/57407—Specifically defined cancers
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers

Similar Documents

Publication Publication Date Title
Cervena et al. Methylation-based therapies for colorectal cancer
Malki et al. Molecular mechanisms of colon cancer progression and metastasis: recent insights and advancements
Zhang et al. DNA methyltransferases in cancer: biology, paradox, aberrations, and targeted therapy
Oue et al. Molecular carcinogenesis of gastric cancer: Lauren classification, mucin phenotype expression, and cancer stem cells
Ho et al. Dissection of gastric cancer heterogeneity for precision oncology
Testa et al. Cellular and molecular mechanisms underlying prostate cancer development: therapeutic implications
Pelosi et al. Pancreatic cancer: molecular characterization, clonal evolution and cancer stem cells
Kamińska et al. Prognostic and predictive epigenetic biomarkers in oncology
Stefansson et al. BRCA1 epigenetic inactivation predicts sensitivity to platinum-based chemotherapy in breast and ovarian cancer
Ng et al. Promoter hypermethylation of tumour suppressor genes as potential biomarkers in colorectal cancer
Kwon et al. Epigenetic regulation of cancer-associated genes in ovarian cancer
Hou et al. The BRAFV600E causes widespread alterations in gene methylation in the genome of melanoma cells
Kurkjian et al. DNA methylation: its role in cancer development and therapy
Treppendahl et al. Predicting response to epigenetic therapy
Kao et al. ETV transcriptional upregulation is more reliable than RNA sequencing algorithms and FISH in diagnosing round cell sarcomas with CIC gene rearrangements
Zhang et al. Targeting loss of heterozygosity: a novel paradigm for cancer therapy
Lan et al. Mutations in the RAS and PI3K pathways are associated with metastatic location in colorectal cancers
Calapre et al. Locus‐specific concordance of genomic alterations between tissue and plasma circulating tumor DNA in metastatic melanoma
Diolaiti et al. A recurrent novel MGA–NUTM1 fusion identifies a new subtype of high-grade spindle cell sarcoma
Angulo et al. The role of epigenetics in the progression of clear cell renal cell carcinoma and the basis for future epigenetic treatments
Testa et al. Genetic alterations of metastatic colorectal cancer
Besaratinia et al. Epigenetics of human melanoma: promises and challenges
Ferraresso et al. DNA methylation profiling reveals common signatures of tumorigenesis and defines epigenetic prognostic subtypes of canine Diffuse Large B-cell Lymphoma
Chu et al. Prognostic values of EPDR1 hypermethylation and its inhibitory function on tumor invasion in colorectal cancer
Hlady et al. Genetic and epigenetic heterogeneity in normal liver homeostasis and its implications for liver disease and hepatocellular cancer